Better Predicting Brain Aneurysm Rupture Risk
Improving Cerebral Aneurysm Risk Assessment through Understanding Wall Vulnerability and Failure Modes
This project aims to understand why some brain aneurysms are more likely to burst, helping doctors decide who needs treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11083027 on NIH RePORTER |
What this research studies
Many people have weak spots in their brain arteries called aneurysms, but only some will rupture, leading to severe health problems. Deciding whether to treat an aneurysm is challenging because current treatments carry their own risks. This work focuses on aneurysms that have small growths, called blebs, which are known to increase the risk of rupture. We want to understand why these blebs form and how they make the aneurysm wall weaker. By studying the structure of these aneurysm walls and how they fail, we hope to develop better ways to identify which aneurysms are truly at high risk of rupturing.
Who could benefit from this research
Good fit: Patients with intracranial aneurysms, especially those with blebs, could be ideal candidates for future applications of this research.
Not a fit: Patients without intracranial aneurysms or those whose aneurysms have already ruptured may not directly benefit from this specific risk assessment research.
Why it matters
Potential benefit: If successful, this work could lead to more accurate ways to identify brain aneurysms at high risk of rupture, helping patients avoid unnecessary risky treatments while ensuring those truly at risk receive timely care.
How similar studies have performed: While the general understanding of aneurysm mechanics exists, this specific focus on bleb formation and failure mechanisms represents a novel approach to improving rupture risk assessment.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Robertson, Anne Marie — University of Pittsburgh at Pittsburgh
- Study coordinator: Robertson, Anne Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.